Tuesday, 29 August 2017
New anti-cancer drug
The new anti-cancer drug, OMO-1, was given to the first cancer patient in the world last week in Oxford University’s Early Phase trials unit. Dr Sarah Blagden (Oxford’s ECMC lead and Director of the Early Phase Trials Unit) is Chief Investigator of this Phase I/II study of the combined c-MET/ OCT-1...
Wednesday, 23 August 2017
Congratulations to student prize winners
The 5th Annual Oncology Student Symposium held at St Anne’s College on Thursday, 13 July was a great success with a full day of talks in the Mary Ogilvie lecture theatre and a poster session in the marquee within the beautiful surroundings of the St Anne’s Quad. The judges commented on how high...
Wednesday, 23 August 2017
Oxford science goes to Durham
Runners at the Framwellgate ParkRun got a taste of cancer research with their morning run on Saturday,15 July. The Department of Oncology teamed up with Framwellgate School (Durham) to reach out to people taking part in the regular 5K run. The Department's Public Engagament Manager, Martin...
Monday, 24 July 2017
Oxford Professor receives Honorary Degree from the Institute of Cancer Research
It was announced in February this year that Professor Adrian Harris had been awarded an Honorary Degree of Doctor of Science (Medicine) of the University of London from the Institute of Cancer Research in recognition of his outstanding contribution to cancer research and treatment. (Pictured left...
Thursday, 20 July 2017
A UNIQ course - Oncology welcomes tomorrow's scientists
On Monday, 24 July the Department of Oncology will welcome 27 students from across the UK who will gather in Oxford to find out what it would be like to study here. During the week the students will live in college accommodation, eatin the halls, experience student life and discover the science...
Friday, 30 June 2017
Oxford collaborative science opens the way for a new drug for bowel cancer patients across the UK
Today a new drug will become available for patients with bowel cancer as part of a national clinical trial; based on a scientific discovery made only two years ago at the University of Oxford. A yeast genetics research group led by Professor Tim Humphrey in Oxford discovered an Achilles heel of...
Friday, 16 June 2017
Medical Research Council - Festival of Medical Research.
Members of the Department of Oncology will be out and about in the community over the next week or so explaining how your tax money is used to fund ground breaking medical research in Oxford. Scientists from all over the world work together to tackle cancer, eczema, and aenemia. Your genes play...
Thursday, 15 June 2017
Green Impact Team silver award
Congratultions to everyone in Old Road Campus Research Building’s Green Impact team, which includes various members of staff from Departments within the Building including Oncology, and also to everyone in the building who has helped achieve a silver award for environmental sustainability projects...
Thursday, 1 June 2017
Researchers make breakthrough discovery in fight against colorectal cancer
New research led by Queen’s University Belfast in collaboration with the University of Oxford, has discovered how a genomic approach to understanding colorectal cancer could improve the prognosis and quality of life for patients. For clinicians, treating patients with bowel cancer can be...
Thursday, 18 May 2017
FOXFIRE Combined Analysis
FOXFIRE Combined Analysis indicates no benefit in overall survival from adding selective internal radiotherapy [SIRT] to first-line oxaliplatin-based chemotherapy for metastatic colorectal cancer. Secondary analyses confirm improved control of liver metastases with liver-directed SIRT and show...
Wednesday, 10 May 2017
100km non-stop in 24 hours
Five members of Professor Len Seymour's laboratory (Arthur Dyer, Sally Frost, Sophie Owen, Tzveta Pokrovska and Ellie Scott) are limbering up to walk 100km non-stop in 24 hours over the August bank holiday to raise money for Cancer Research UK, Martlet's Hospice and the Red Cross. If you have any...
Friday, 5 May 2017
Video makers visit the Department of Oncology
Last September, a challenge went out to schools to make a two-minute video to explain our science to the public. Over 30 teams of students rose to the challenge. On 5 April, the top six entries visited the Department of Oncology to collect their prizes and take advantage of the opportunity to...
Monday, 10 April 2017
2016 Oxford Harrington Scholarship
It was announced in August 2016 that Professor Valentine Macaulay was awarded the 2016 Oxford Harrington Scholarship. Professor Macaulay’s work focuses on understanding growth factor receptor function, and the award was given to support novel approaches to disrupt receptor function as therapy for...
Friday, 7 April 2017
Cancer Research UK Boat Race
Joshua Bugajski (Stroke 4), an MSc Oncology student in Katherine Vallis’ group was part of Oxford’s winning team on Sunday, 2 April when they cruised to victory in the 2017 Cancer Research UK boat race against Cambridge. Oxford won the toss and chose the Surrey station. The crew took an early...
Monday, 27 March 2017
New era in precision medicine for pancreatic cancer
The development of new treatments for pancreatic cancer is set to be transformed by a network of pancreatic clinical trials, aiming to find the right trial for the right patient, after a £10 million investment from Cancer Research UK announced today. The investment will support the PRECISION Panc...
Monday, 13 February 2017
Viruses killing cancer cells: stimulating an immune response within the cancer microenvironment
Monday, 12 December 2016
Bubbles, ultrasound and radiotherapy: creating a new approach to drug delivery
Monday, 31 October 2016
University of Oxford researchers awarded more than £140,000 to develop new techniques to detect pancreatic cancer
We aim to enhance clinical and basic cancer research in Oxford with the ultimate goal of increasing cancer cure rates.
In Oxford, we have a great wealth of broad-ranging expertise and a powerful network of cancer researchers.
Study With Us
Our graduate training programmes for both scientists and clinicians are internationally recognised.